PILA PHARMA INKS AGREEMENT WITH LINDUS HEALTH ABOUT NEXT CLINICAL TRIAL WITH SAFETY AND OBESITY READOUTS
Announcing our Phase 2a clinical trial with PILA PHARMA to assess the tolerability, safety, and efficacy of XEN-D0501 in patients with type II diabetes and obesity.